{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:35:18Z","timestamp":1792791318763,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.gim.2021.12.013","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T17:33:08Z","timestamp":1644514388000},"page":"769-783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Measurement of lysosomal enzyme activities: A technical standard of the American College of Medical Genetics and Genomics (ACMG)"],"prefix":"10.1016","volume":"24","author":[{"given":"Erin T.","family":"Strovel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Cusmano-Ozog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunli","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gim.2021.12.013_bib1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41572-018-0037-0","article-title":"Author correction: lysosomal storage diseases","volume":"4","author":"Platt","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.gim.2021.12.013_bib2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev-med-122313-085916","article-title":"Lysosomal storage diseases: from pathophysiology to therapy","volume":"66","author":"Parenti","year":"2015","journal-title":"Annu Rev Med"},{"issue":"2","key":"10.1016\/j.gim.2021.12.013_bib3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.tibs.2018.10.006","article-title":"Lysosomal ion channels as decoders of cellular signals","volume":"44","author":"Li","year":"2019","journal-title":"Trends Biochem Sci"},{"issue":"4","key":"10.1016\/j.gim.2021.12.013_bib4","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.bbamcr.2008.10.016","article-title":"Sorting of lysosomal proteins","volume":"1793","author":"Braulke","year":"2019","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/j.gim.2021.12.013_bib5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ymgme.2008.04.012","article-title":"GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects","volume":"94","author":"Brunetti-Pierri","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.gim.2021.12.013_bib6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1750-1172-7-86","article-title":"Lysosomal storage disorder in non-immunological hydrops fetalis (NIHF): more common than assumed? Report of four cases with transient NIHF and a review of the literature","volume":"7","author":"Whybra","year":"2012","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.gim.2021.12.013_bib7","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1373\/clinchem.2005.048553","article-title":"Newborn screening for lysosomal storage disorders","volume":"51","author":"Millington","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.gim.2021.12.013_bib8","series-title":"Pediatric Endocrinology and Inborn Errors of Metabolism","first-page":"983","article-title":"Lysosomal disorders","author":"Giugliani","year":"2017"},{"key":"10.1016\/j.gim.2021.12.013_bib9","series-title":"The Metabolic and Molecular Bases of Inherited Diseases","first-page":"3635","article-title":"Gaucher disease","author":"Beutler","year":"2001"},{"issue":"4","key":"10.1016\/j.gim.2021.12.013_bib10","first-page":"855","article-title":"High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews","volume":"49","author":"Zimran","year":"1991","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.gim.2021.12.013_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/ijns6010009","article-title":"The first year experience of newborn screening for Pompe disease in California","volume":"6","author":"Tang","year":"2020","journal-title":"Int J Neonatal Screen"},{"issue":"3","key":"10.1016\/j.gim.2021.12.013_bib12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/gim.2015.211","article-title":"Newborn screening for Krabbe disease in New York State: the first eight years\u2019 experience","volume":"18","author":"Orsini","year":"2016","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.gim.2021.12.013_bib13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/ijns6020044","article-title":"A\u00a0comparative effectiveness study of newborn screening methods for four lysosomal storage disorders","volume":"6","author":"Sanders","year":"2020","journal-title":"Int J Neonatal Screen"},{"issue":"8","key":"10.1016\/j.gim.2021.12.013_bib14","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/jhg.2013.48","article-title":"Newborn screening for Fabry disease in Japan: prevalence and genotypes of Fabry disease in a pilot study","volume":"58","author":"Inoue","year":"2013","journal-title":"J\u00a0Hum Genet"},{"issue":"1","key":"10.1016\/j.gim.2021.12.013_bib15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jpeds.2014.09.023","article-title":"Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri","volume":"166","author":"Hopkins","year":"2015","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.gim.2021.12.013_bib16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1750-1172-8-92","article-title":"Clinical manifestations in female carriers of mucopolysaccharidosis type II: a Spanish cross-sectional study","volume":"8","author":"Guill\u00e9n-Navarro","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"10.1016\/j.gim.2021.12.013_bib17","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.38.11.769","article-title":"Anderson\u2013Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females","volume":"38","author":"MacDermot","year":"2001","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.gim.2021.12.013_bib18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijcard.2019.01.020","article-title":"Danon disease: gender differences in presentation and outcomes","volume":"286","author":"Brambatti","year":"2019","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.gim.2021.12.013_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijns5010001","article-title":"Newborn screening for lysosomal storage disorders: methodologies for measurement of enzymatic activities in dried blood spots","volume":"5","author":"Gelb","year":"2019","journal-title":"Int J Neonatal Screen"},{"issue":"3","key":"10.1016\/j.gim.2021.12.013_bib20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ddrr.1117","article-title":"Newborn screening for lysosomal storage disorders and other neuronopathic conditions","volume":"17","author":"Matern","year":"2013","journal-title":"Dev Disabil Res Rev"},{"issue":"5","key":"10.1016\/j.gim.2021.12.013_bib21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/GIM.0b013e318211a7e1","article-title":"Lysosomal storage diseases: diagnostic confirmation and management of presymptomatic individuals","volume":"13","author":"Wang","year":"2011","journal-title":"Genet Med"},{"issue":"8","key":"10.1016\/j.gim.2021.12.013_bib22","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/hmg\/7.8.1215","article-title":"Importance of the glycosylation and polyadenylation variants in metachromatic leukodystrophy pseudodeficiency phenotype","volume":"7","author":"Harvey","year":"1998","journal-title":"Hum Mol Genet"},{"issue":"23","key":"10.1016\/j.gim.2021.12.013_bib23","doi-asserted-by":"crossref","first-page":"9436","DOI":"10.1073\/pnas.86.23.9436","article-title":"Arylsulfatase A pseudodeficiency: loss of a polyadenylylation signal and N-glycosylation site","volume":"86","author":"Gieselmann","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.gim.2021.12.013_bib24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ymgme.2008.02.012","article-title":"Maroteaux-Lamy syndrome: functional characterization of pathogenic mutations and polymorphisms in the arylsulfatase B gene","volume":"94","author":"Garrido","year":"2008","journal-title":"Mol Genet Metab"},{"issue":"11","key":"10.1016\/j.gim.2021.12.013_bib25","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s10038-007-0191-9","article-title":"Structural and biochemical studies on Pompe disease and a \u201cpseudodeficiency of acid alpha-glucosidase\u201d","volume":"52","author":"Tajima","year":"2007","journal-title":"J\u00a0Hum Genet"},{"issue":"5","key":"10.1016\/j.gim.2021.12.013_bib26","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1399-0004.1988.tb03465.x","article-title":"Km mutant of acid alpha-glucosidase in a case of cardiomyopathy without signs of skeletal muscle involvement","volume":"33","author":"Suzuki","year":"1988","journal-title":"Clin Genet"},{"issue":"8","key":"10.1016\/j.gim.2021.12.013_bib27","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/ejhg.2008.34","article-title":"p.[G576S; E689K]: pathogenic combination or polymorphism in Pompe disease?","volume":"16","author":"Kroos","year":"2008","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"10.1016\/j.gim.2021.12.013_bib28","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.gene.2013.11.003","article-title":"Late-onset Krabbe disease is predominant in Japan and its mutant precursor protein undergoes more effective processing than the infantile-onset form","volume":"534","author":"Hossain","year":"2014","journal-title":"Gene"},{"issue":"6","key":"10.1016\/j.gim.2021.12.013_bib29","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/humu.10275","article-title":"Fabry disease: characterization of alpha-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele","volume":"22","author":"Yasuda","year":"2003","journal-title":"Hum Mutat"},{"issue":"3","key":"10.1016\/j.gim.2021.12.013_bib30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/humu.20147","article-title":"Role of beta-galactosidase and elastin binding protein in lysosomal and nonlysosomal complexes of patients with GM1-gangliosidosis","volume":"25","author":"Caciotti","year":"2005","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1016\/j.gim.2021.12.013_bib31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1399-0004.2007.00843.x","article-title":"Identification of a novel pseudodeficiency allele in the GLB1 gene in a carrier of GM1 gangliosidosis","volume":"72","author":"Gort","year":"2007","journal-title":"Clin Genet"},{"issue":"23","key":"10.1016\/j.gim.2021.12.013_bib32","doi-asserted-by":"crossref","first-page":"14975","DOI":"10.1074\/jbc.272.23.14975","article-title":"Benign HEXA mutations, C739T(R247W) and C745T(R249W), cause beta-hexosaminidase A pseudodeficiency by reducing the alpha-subunit protein levels","volume":"272","author":"Cao","year":"1997","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.gim.2021.12.013_bib33","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41436-018-0129-y","article-title":"The New York pilot newborn screening program for lysosomal storage diseases: report of the first 65,000 infants","volume":"21","author":"Wasserstein","year":"2019","journal-title":"Genet Med"},{"issue":"Suppl 2","key":"10.1016\/j.gim.2021.12.013_bib34","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13052-018-0552-3","article-title":"Newborn screening in mucopolysaccharidoses","volume":"44","author":"Donati","year":"2018","journal-title":"Ital J Pediatr"},{"issue":"1","key":"10.1016\/j.gim.2021.12.013_bib35","first-page":"75","article-title":"Molecular genetic defect underlying alpha-L-iduronidase pseudodeficiency","volume":"58","author":"Aronovich","year":"1996","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.gim.2021.12.013_bib36","series-title":"Techniques on Diagnostic Human Biochemical Genetics. A Laboratory Manual","first-page":"587","article-title":"Screening for lysosomal disorders","author":"Wenger","year":"1991"},{"issue":"4","key":"10.1016\/j.gim.2021.12.013_bib37","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1373\/clinchem.2016.259036","article-title":"Liquid chromatography-tandem mass spectrometry assay of leukocyte acid \u03b1-glucosidase for post-newborn screening evaluation of Pompe disease","volume":"63","author":"Lin","year":"2017","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.gim.2021.12.013_bib38","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1373\/clinchem.2008.111864","article-title":"Development and evaluation of quality control dried blood spot materials in newborn screening for lysosomal storage disorders","volume":"55","author":"De Jesus","year":"2009","journal-title":"Clin Chem"},{"issue":"RR-2","key":"10.1016\/j.gim.2021.12.013_bib39","first-page":"1","article-title":"Good laboratory practices for biochemical genetic testing and newborn screening for inherited metabolic disorders","volume":"61","year":"2012","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"10.1016\/j.gim.2021.12.013_bib40","first-page":"17.7.1","article-title":"Management and quality assurance in the biochemical genetics laboratory","volume":"59","author":"Cowan","year":"2008","journal-title":"Curr Protoc Hum Genet"},{"issue":"6","key":"10.1016\/j.gim.2021.12.013_bib41","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1023\/A:1012763026526","article-title":"A\u00a0fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease)","volume":"24","author":"Voznyi","year":"2001","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"2","key":"10.1016\/j.gim.2021.12.013_bib42","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0009-8981(90)90339-T","article-title":"A\u00a0fluorimetric enzyme assay for the diagnosis of Morquio disease type A (MPS IV A)","volume":"187","author":"van Diggelen","year":"1990","journal-title":"Clin Chim Acta"},{"issue":"15-16","key":"10.1016\/j.gim.2021.12.013_bib43","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cca.2012.03.019","article-title":"A\u00a0new method for the measurement of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2","volume":"413","author":"Hamilton","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.gim.2021.12.013_bib44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cca.2017.05.027","article-title":"Best practice in the measurement and interpretation of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2","volume":"471","author":"Lukacs","year":"2017","journal-title":"Clin Chim Acta"},{"issue":"2","key":"10.1016\/j.gim.2021.12.013_bib45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/ijns1020069","article-title":"Influence of hematocrit and total-spot volume on performance characteristics of dried blood spots for newborn screening","volume":"1","author":"Hall","year":"2015","journal-title":"Int J Neonatal Screen"},{"issue":"12","key":"10.1016\/j.gim.2021.12.013_bib46","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1373\/clinchem.2008.115410","article-title":"Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis I","volume":"54","author":"Blanchard","year":"2008","journal-title":"Clin Chem"},{"issue":"10","key":"10.1016\/j.gim.2021.12.013_bib47","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1373\/clinchem.2008.104711","article-title":"Multiplex enzyme assay screening of dried blood spots for lysosomal storage disorders by using tandem mass spectrometry","volume":"54","author":"Zhang","year":"2008","journal-title":"Clin Chem"},{"issue":"10","key":"10.1016\/j.gim.2021.12.013_bib48","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1373\/clinchem.2004.035907","article-title":"Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening","volume":"50","author":"Li","year":"2004","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.gim.2021.12.013_bib49","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1373\/clinchem.2003.028381","article-title":"Tandem mass spectrometry for the direct assay of enzymes in dried blood spots: application to newborn screening for Krabbe disease","volume":"50","author":"Li","year":"2004","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.gim.2021.12.013_bib50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1373\/clinchem.2006.077263","article-title":"Tandem mass spectrometry for the direct assay of enzymes in dried blood spots: application to newborn screening for mucopolysaccharidosis II (Hunter disease)","volume":"53","author":"Wang","year":"2007","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.gim.2021.12.013_bib51","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1021\/bc200609x","article-title":"New substrates and enzyme assays for the detection of mucopolysaccharidosis III (Sanfilippo syndrome) types A, B, C, and D by tandem mass spectrometry","volume":"23","author":"Wolfe","year":"2012","journal-title":"Bioconjug Chem"},{"issue":"1","key":"10.1016\/j.gim.2021.12.013_bib52","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1373\/clinchem.2010.149880","article-title":"Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis IVA","volume":"57","author":"Khaliq","year":"2011","journal-title":"Clin Chem"},{"issue":"22","key":"10.1016\/j.gim.2021.12.013_bib53","doi-asserted-by":"crossref","first-page":"9587","DOI":"10.1021\/ac102090v","article-title":"Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)","volume":"82","author":"Duffey","year":"2010","journal-title":"Anal Chem"},{"issue":"15","key":"10.1016\/j.gim.2021.12.013_bib54","doi-asserted-by":"crossref","first-page":"7962","DOI":"10.1021\/ac501994b","article-title":"Tandem mass spectrometry assays of palmitoyl protein thioesterase 1 and tripeptidyl peptidase activity in dried blood spots for the detection of neuronal ceroid lipofuscinoses in newborns","volume":"86","author":"Barcenas","year":"2014","journal-title":"Anal Chem"},{"issue":"6","key":"10.1016\/j.gim.2021.12.013_bib55","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1373\/clinchem.2016.269167","article-title":"Multiplex tandem mass spectrometry enzymatic activity assay for newborn screening of the mucopolysaccharidoses and type 2 neuronal ceroid lipofuscinosis","volume":"63","author":"Liu","year":"2017","journal-title":"Clin Chem"},{"issue":"15","key":"10.1016\/j.gim.2021.12.013_bib56","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.1021\/ac900504s","article-title":"New strategy for the screening of lysosomal storage disorders: the use of the online trapping-and-cleanup liquid chromatography\/mass spectrometry","volume":"81","author":"la Marca","year":"2009","journal-title":"Anal Chem"},{"key":"10.1016\/j.gim.2021.12.013_bib57","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cca.2013.05.001","article-title":"Multiplex newborn screening for Pompe, Fabry, Hunter, Gaucher, and Hurler diseases using a digital microfluidic platform","volume":"424","author":"Sista","year":"2013","journal-title":"Clin Chim Acta"},{"issue":"11","key":"10.1016\/j.gim.2021.12.013_bib58","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1373\/clinchem.2015.242560","article-title":"Tandem mass spectrometry has a larger analytical range than fluorescence assays of lysosomal enzymes: application to newborn screening and diagnosis of mucopolysaccharidoses types II, IVA, and VI","volume":"61","author":"Kumar","year":"2015","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.gim.2021.12.013_bib59","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0092-8674(95)90314-3","article-title":"A\u00a0novel amino acid modification in sulfatases that is defective in multiple sulfatase deficiency","volume":"82","author":"Schmidt","year":"1995","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.gim.2021.12.013_bib60","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ajmg.a.38023","article-title":"Hereditary fructose intolerance mimicking a biochemical phenotype of mucolipidosis: a review of the literature of secondary causes of lysosomal enzyme activity elevation in serum","volume":"173","author":"Ferreira","year":"2017","journal-title":"Am J Med Genet A"},{"issue":"1 suppl 1","key":"10.1016\/j.gim.2021.12.013_bib61","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1590\/1678-4685-gmb-2018-0159","article-title":"Lysosomal diseases: overview on current diagnosis and treatment","volume":"42","author":"Poswar","year":"2019","journal-title":"Genet Mol Biol"},{"issue":"suppl 3","key":"10.1016\/j.gim.2021.12.013_bib62","doi-asserted-by":"crossref","first-page":"S192","DOI":"10.1007\/PL00014401","article-title":"Population-based genetic screening for reproductive counseling: the Tay-Sachs disease model","volume":"159","author":"Kaback","year":"2000","journal-title":"Eur J Pediatr"},{"issue":"1","key":"10.1016\/j.gim.2021.12.013_bib63","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/GIM.0b013e31815f6eac","article-title":"Technical standards and guidelines for reproductive screening in the Ashkenazi Jewish population","volume":"10","author":"Monaghan","year":"2008","journal-title":"Genet Med"},{"issue":"8","key":"10.1016\/j.gim.2021.12.013_bib64","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3109\/00365519509075402","article-title":"Plasma beta-hexosaminidase isoenzymes A and B exhibit different relations to blood glucose levels in a population of type 1 diabetic patients","volume":"55","author":"Hultberg","year":"1995","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.gim.2021.12.013_bib65","first-page":"459","article-title":"Beta-hexosaminidase in the detection of alcoholism and heavy drinking","volume":"1","author":"K\u00e4rkk\u00e4inen","year":"1991","journal-title":"Alcohol Alcohol Suppl"},{"issue":"3","key":"10.1016\/j.gim.2021.12.013_bib66","first-page":"223","article-title":"The activity of n-acetyl-\u03b2-hexosaminidase and its isoenzymes in serum of children with chronic hepatitis","volume":"10","author":"Arciuch","year":"2003","journal-title":"Gastroenterol Pol"},{"key":"10.1016\/j.gim.2021.12.013_bib67","first-page":"7","article-title":"N-acetyl-\u03b2-hexosaminidase with biochemical and morphological parameters in autoimmune liver diseases","volume":"3","author":"Kna\u015b","year":"2007","journal-title":"Exp Clin Hepatol"},{"issue":"9","key":"10.1016\/j.gim.2021.12.013_bib68","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1089\/gtmb.2015.0302","article-title":"Tay-Sachs carrier screening by enzyme and molecular analyses in the New York City minority population","volume":"20","author":"Mehta","year":"2016","journal-title":"Genet Test Mol Biomarkers"}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360021054721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360021054721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:52:41Z","timestamp":1761097961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360021054721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1098360021054721"],"URL":"https:\/\/doi.org\/10.1016\/j.gim.2021.12.013","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measurement of lysosomal enzyme activities: A technical standard of the American College of Medical Genetics and Genomics (ACMG)","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gim.2021.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American College of Medical Genetics and Genomics. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}